Skip to main content
All lobbying filings

DANA-FARBER CANCER INSTITUTE

Lobbying for DANA-FARBER CANCER INSTITUTE

 Filing 4th Quarter - Amendment
4th Quarter (Oct 1 - Dec 31) 2025 · Massachusetts · House · Senate · $89,000.00 expenses · posted Jan 21, 2026

Official filing document

 Bills named in this filing 3
  • HR 1262
    Mikaela Naylon Give Kids a Chance Act
  • HR 1509
    Accelerating Kids’ Access to Care Act of 2025
  • HR 1300
    PSA Screening for HIM Act
 Lobbying activity 5
Medical/Disease Research/Clinical Labs

Support policies to remove barriers to clinical trials, promote research generally, address issues in childhood cancer research including 1509/ S 752 the Accelerating Kids Access to Care Act and HR 1262 the Give Kids a Chance Act

Tobacco

Support for FDA's role to vigorously enforce the Family Smoking Prevention and Tobacco Control Act including the regulation of flavors, menthol and small cigars. Support for continued funding for the CDCs Office on Smoking and Health.

Health Issues

Issues related to quality of life, survivorship and access for cancer patients including HR 1509/ S 752 the Accelerating Kids Access to Care Act, HR 1262 the Give Kids a Chance Act and HR 1300/S 297 the Prostate-Specific Antigen Screening for High-Risk Insured Men (PSA Screening for HIM) Act.

Medicare/Medicaid

Issues related to health care access and reimbursement through the Medicare and Medicaid programs including site neutrality and prior authorization policies in the Medicare and Medicare Advantage program

Budget/Appropriations

Funding related to biomedical and cancer research and innovation at the NIH and NCI, funding for Childhood Cancer research, funding for ARPA-H in the Labor, Health and Human Services, Education bill; funding for cancer prevention and smoking cessation programs at the CDC.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem